FIGURE 2 3.3 Severe versus non-severe cases As shown in Table 3, with the exception of lixisenatide (n = 14), which was not included because the number of AEs was insufficient for analysis, differential analyses of gender, age, and body weight were performed between severe and non-severe cases in patients with AEs of metabolism and nutrition disorders who were treated with the remaining six GLP-1 RAs
Careful and targeted patient selection are required, alongside robust education and novel technologies to monitor glucose and ketone levels to mitigate the risks and enhance the beneficial effects of SGLT2i and GLP-1 RA therapy
This context may help support a more informed conversation with your provider about whether semaglutide, tirzepatide, or a dual-agonist protocol aligns with your metabolic biology
Recent advances in formulating electrospun nanofiber membranes: delivering active phytoconstituents
However, many women experience hair loss during menopause and pregnancy due to a decrease in B12 and other nutrients
Proper diagnosis ensures appropriate treatment
.png)
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
